An electrophoretic mobility shift assay was used to characterize interactions of nuclear proteins with a DNA segment in the enhancer element of the leukemogenic murine retrovirus SL3-3. Mutation of a DNA sequence of the 5'-TGTGG-3' type decreased transcription in vivo specifically in T-lymphocyte cell lines. Extracts of nuclei from different T-lymphocyte cell lines or cells from lymphoid organs resulted in much higher amounts of complexes in vitro with this DNA sequence than did extracts from other cell lines or organs tested. Differences were also found in the sets of complexes obtained with extracts from the different types of cells. The DNA sequence specificities of the different SL3-3 enhancer factor 1 (SEFI) protein complexes were found to be distinct from those of several other previously identified DNA motifs of the TGTGG type because of differences in several nucleotides critical for binding and because these other DNA motifs could not compete with the identified DNA sequence for binding of SEF1. Limited treatment with several different proteases cleaved the SEF1 proteins such that their DNA-binding domain(s) remained and created complexes with decreased and nondistinguishable electrophoretic mobility shifts and with new properties. These results indicate that the SEF1 proteins have a structure with a flexible and relatively vulnerable hinge region linking a DNA-binding domain(s) to a more variable domain(s) with other functions. We suggest that the binding of SEFI is an essential factor for the T-cell tropism of SL3-3 and the ability of this virus to cause T-cell lymphomas.
Regulatory elements, denoted enhancers, that can potentiate transcription from a variety of promoters in a relatively distance-and orientation-independent manner were originally defined in viruses and subsequently also identified for chromosomal genes (for reviews, see references 8, 19, 31, and 61) . Results of competition experiments in vitro (57, 62, 75) and in vivo (45, 59) have shown that specific trans-acting factors are involved in enhancer function. The enhancer activity of simian virus 40 (SV40) has been shown to result from the integrated function of multiple sequence elements (79) which bind such factors (76) . Results of studies of several other enhancers both in vivo and in vitro have supported the notion of a modular organization of enhancers based upon shorter sequence elements (79) . Homologies between such sequence elements have also been found for enhancers with very different cell type specificities. The first noted and most commonly found homology between enhancers is an element with 5'-TGTGG-3' as its most conserved sequence feature (23, 31, 40, 53, 72, 73) .
Enhancers have been shown to display several distinct properties that are indicative of a high degree of flexibility. (i) They can function when separated from the promoter by a long distance of DNA. (ii) They can, without displaying symmetry in their DNA sequences, function irrespective of their orientations relative to the promoter. (iii) Their sequence motifs can be rearranged without loss of enhancer activity (8, 19, 31, 61, 79) . However, a certain stereospecific alignment of an enhancer to a promoter is needed for the optimal level of enhancement (67) . Because of these properties, Takahashi et al. (67) presented a hypothesis that proteins binding to the enhancer may be composed of two distinct functional domains, a DNA-binding domain and a protein-interacting domain, with the two domains linked by a flexible stem. Such a type of protein structure has been demonstrated for procaryotic DNA-binding proteins: the * Corresponding author. lambda repressor CI (26, 50, 74) , the lambda Cro protein (10, 68 , and references therein), the catabolite activator protein CAP (44) , and the LexA protein (39) .
SL3-3 is a murine retrovirus which has been shown to induce T-cell lymphomas in several strains of mice, usually 2 to 4 months postinoculation (37, 51) . The T-lymphocytespecific leukemogenicity of this virus has been localized to its long terminal repeat (LTR) (36) , which contains an enhancer which is preferentially active in T lymphocytes and is believed to be the leukemogenic determinant of this virus (7) . This LTR contains a 72-base-pair (bp)-long duplicated DNA segment followed by a third copy of the first 34 bp of the repeat (36) . We have localized the most important sequences for the enhancer activity in T lymphocytes to these repeated sequences (B. Hallberg and T. Grundstrom, manuscript in preparation). At least a part of this activity was shown to reside in the duplicated 38-bp DNA segment containing a sequence belonging to the TGTGG group of commonly found enhancer DNA motifs.
We report here on the interactions of nuclear proteins with the TGTGG sequence of SL3-3, as detected by DNase I footprinting and further characterized by an electrophoretic mobility shift assay (12, 16) . This latter technique, which resolves nucleoprotein complexes from uncomplexed DNA by electrophoresis through polyacrylamide gels, has been used for the analysis of a number of procaryotic and eucaryotic DNA-binding proteins (6, 13, 14, 24, 25, 38, 52, 64, 66) .
In this report we show that when nuclear extracts from different cell lines are allowed to interact with the TGTGG sequence of the SL3-3 enhancer, a set of sequence-specific protein-DNA complexes with different electrophoretic mobilities are obtained. We found that the SL3-3 enhancer factor 1 (SEF1) proteins creating these complexes are much more abundant in cell lines of T lymphocytes and in lymphoid organs than in the other cell lines and organs tested. Mutation of the SEFl-binding site on the DNA decreased transcription in vivo in two T-lymphocyte cell lines, in contrast to results obtained with other cells. The results argue for the notion that the T-lymphocyte preference in the activity of the 38-bp repeat of the enhancer is due to the quantitative differences in the SEF1 proteins or differences in the sets of such proteins in the different cell types or both. We also show that limited treatments with proteases cleaved the different SEF1 proteins such that their DNA-binding domain(s) remained and created complexes with nondistinguishable electrophoretic mobilities and with new properties. These results indicate that the proteins we have studied have a flexible and vulnerable hinge region linking a DNA-binding domain(s) and a more variable domain(s) with other functions.
MATERIALS AND METHODS
Cell lines. The following cell lines were used: X-63 Ag8.653 (denoted in the text as X-63-1), a nonimmunoglobulin-secreting mouse myeloma (29, 34) ; K46-R, a subclone of the mouse B-cell lymphoma K46 (32) ; EL-4, a mouse Thelper-cell lymphoma (20, 46) ; CTL, a monoclonal cytotoxic mouse T-cell line (2); J558L, a mouse myeloma (49); BA-LENTL 13, a mouse T-helper-cell line (33) ; Jurkat, a human T-helper-cell line (18) ; and HeLa, a human carcinoma cell line. The lymphocyte cell lines were grown in culture flasks or Spinner flasks with RPMI 1640 medium supplemented with 5% fetal bovine serum, 5 ,ug of insulin per ml, 5 jig of transferrin per ml, 5 ng of selenium per ml, 37 .5 x 106 U of streptomycin per ml, 5 .0 x 107 U of benzylpenicillin per ml, 1 mM sodium pyruvate, and 20 mM ,-mercaptoethanol. For CTL, which is dependent on interleukin-2, the medium was supplemented with 40 U of interleukin-2 per ml, which was prepared as described by Robb et al. (54) and assayed as described by Kappler et al. (28) . HeLa cells were grown as described by Banerji et al. (4) .
Preparation of nuclear extracts. For the preparation of nuclear extracts, 5 x 108 to 10 x 108 cells were harvested by centrifugation in a rotor (2,000 rpm, 10 min; GS-3; Sorvall), suspended in culture medium, pooled, centrifuged (2,000 rpm, 10 min), suspended in phosphate-buffered saline (140 mM NaCl, 2.7 mM KCl, 14 mM Na2HPO4, 1.5 mM KH2PO4, 0.5 mM MgCl2, 0.7 mM CaCl2), and centrifuged again (as described above). Spleen and thymus cells were prepared from fresh organs of 20 CBA mice or 1 calf by slicing and grinding them through a metal net, followed by washing with phosphate-buffered saline. The cells were incubated on ice for 10 min, and then the supernatant was carefully decanted and centrifugated at 500 rpm for 10 min in a centrifuge (TJ-6; Beckman Instruments, Inc., Fullerton, Calif.). After a new decantation, the supernatant was centrifugated at 2,000 rpm for 10 min to pellet the spleen cells. Liver and kidney nuclei were prepared from fresh organs from four CBA mice as described by Graves et al. (21) .
Nuclear extracts were prepared from the cell pellets as described by Dignam et al. (11) , with the modifications of Wildeman et al. (75) and the additional modification that the protease inhibitor phenylmethylsulfonyl fluoride (PMSF; 1 mM) and, when nothing else is specified below, the protease inhibitors leupeptin (5 ,ug/ml), pepstatin A (2.5 jig/ml), aprotinin (12 ,ug/ml), benzamidine (2 mg/ml), soybean trypsin inhibitor (12 ,g/ml), and chicken egg white ovomucoid containing ovoinhibitor (12 ,ug/ml) were also added to the buffers. Protein concentrations of extracts were typically 5 to 15 ,ug/,ul.
DNase I footprinting experiments. Plasmid pESG106 (Hallberg and Grundstrom, in preparation), a derivative of plasmid pA51 (79) , containing a synthesized 317-bp DNA segment from SL3-3 virus (positions 130 to 446; nucleotide numbers are those used in reference 36) including most of the U3 region of the LTR, was cleaved with the restriction endonuclease KpnI (a cleavage site constructed at position 130). Two complementary synthetic oligonucleotides, a 34-mer and an 18-mer, creating the sticky end of restriction endonuclease KpnI and an end with a 5' extension of 10 T residues, were prepared with the rapid microscale segmented synthesis technique (42) modified for phosphoamidite chemistry (H. W. D. Matthes, A. Staub, and P. Chambon, Methods Enzymol., in press). The 34-mer was phosphorylated with T4 polynucleotide kinase (Boehringer GmbH, Mannheim, Federal Republic of Germany), the two oligonucleotides were annealed (37°C, 15 min), the KpnIcleaved vector was added, the synthetic DNA segments were ligated with T4 DNA ligase, and then a fill-in reaction was performed with [a-32P]dATP (3,000 Ci/mmol; Amersham International) and the Klenow fragment of DNA polymerase I (Boehringer). The DNA was extracted with phenol-chloroform, precipitated with ethanol, cleaved with the restriction endonuclease BamHI (position 446), extracted with phenol-chloroform again, and separated on a native 5% polyacrylamide gel (acrylamide-bisacrylamide [19/1] ). The gel was autoradiographed wet, and the proper DNA segment was excised, electroeluted (41) , extracted with phenol-chloroform, and precipitated with ethanol. Footprinting reactions were based on the methods of Galas and Schmitz (15) and Ohlsson and Edlund (48) , with the following slight modifications; 0.1 to 0.2 fmol of end-labeled DNA, 1 ,ug of poly(dI-dC) (Pharmacia, Uppsala, Sweden), 3 to 10 ,ul of nuclear extract (prepared in the presence of PMSF), and 12.5 to 400 ng of DNase I (Sigma Chemical Co., St. Louis, Mo.; adjusted empirically to produce an even pattern of cleavage products) were used in a total reaction volume of 20 ,ul. The DNA fragments were separated on 6% polyacrylamide buffer gradient urea gels (5) .
Construction of mutants and in vivo transcription assay. Plasmid pESG134 (Hallberg and Grundstrom, in preparation; Fig. 1A ) is a derivative of plasmid pA51 (79) , containing a version of the SL3-3 enhancer with two copies of the 34-bp repeat and one copy of the 38-bp segment in front of the SV40 early promoter region (positions 101 to 5171) (69) and the coding sequence of the rabbit 3-globin gene (positions -9 to +1330) (70) in pBR322 between positions 4361 and 2296. The derivative of plasmid pESG134 containing mutation 2 was constructed by cassette mutagenesis using the shotgun ligation technique (22) . In summary, the PstI-ApaI DNA segment containing the mutation (positions 37 to 203) (36) was assembled from the same set of 15 oligonucleotides as that employed for the synthesis of pESG134 (Hallberg and Grundstrom, in preparation), except that the proper nucleotides to create the substitution of three nucleotides were replaced. The assembly was confirmed by dideoxy sequencing, and a plasmid identical to pESG134, except for the mutation, was constructed by standard subcloning techniques. The cotransfected reference plasmid pESGO03 (Hallberg and Grundstrom, in preparation) has a structure corresponding to that of pESG134, except that the enhancer is that of SV40 (positions 107 to 299) (69) and the promoter is that of rabbit ,-globin (complete to position -113).
Transfections of lymphocytes were as described by Ba Methylation interference experiments. DNA segments of 31 bp, which were labeled at one 5' end by annealing one labeled and one unlabeled oligonucleotide, were partially methylated at the guanine and adenine residues, as described by Siebenlist and Gilbert (63) . The electrophoretic mobility shift assays were performed with extracts prepared in the presence of PMSF in a 20-fold larger scale than that described above. Bands were excised from the dried gels and eluted overnight in water containing 10 To analyze whether a nuclear factor(s) bound to the LTR of SL3-3 virus, the enhancer was 3' end labeled with 32p on its upstream side (at nucleotide position 130; numbering as in reference 36), incubated with nuclear extract from the murine cytotoxic T-lymphocyte cell line CTL, and subsequently treated with DNase I (see above). The nuclear extract very specifically modified the pattern of digestion characteristic of naked DNA (cf. lanes 3 and 4 of Fig. 1B) . A 17-bp-long sequence in the duplicated 38-bp DNA segment (positions 178 to 193 and 251 to 265) was specifically protected against DNase I digestion. This DNA segment (5'-GATATCTGTGGT TAAGC-3') has an enhancer motif of the TGTGG type in its center. However, with extracts from other cell types, the footprinting technique did not demonstrate clear and reproducible interactions over this DNA segment (data not shown).
Effects of a mutation in the interaction sequence on transient expression. Deletion of the remaining 38-bp repeat from a derivative of the SL3-3 enhancer carrying one copy each of the 34-and 38-bp repeats decreases transcription about twofold in the T-lymphocyte cell lines CTL and EL-4, while it does not decrease transcription in the B-cell line X-63-1 or HeLa cells (Hallberg and Grundstrom, in preparation). To study whether the interaction with the identified DNA sequence was relevant for the selective effect of the 38-bp repeat seqence on transcription in vivo in T lymphocytes, the enhancement of transcription during transient expression of a mutant in the sequence protected against DNase I and the corresponding wild type were compared. Plasmid pESG134 ( Fig. 1A ; Hallberg and Grundstrom, in preparation), carrying the SL3-3 enhancer in front of the early promoters of SV40 and a rabbit P-globin gene, was used for these experiments. This plasmid has one 72-bp repeat of the LTR of SL3-3 deleted and therefore contains a single copy of the TGTGG sequence. This deletion has small effects on the shown in Fig. 2 , and these results, together with additional measurements, are summarized in Table 1 . As expected from the lack of effect of deleting the 38-bp repeat in the B-cell line X-63-1, we found no effect of the mutation on the level of transcription in this cell line. Interestingly, the mutation of the 38-bp repeat decreased transcription twofold in both T-lymphocyte cell lines tested, strongly arguing that the selective twofold effect of the 38-bp repeat on transcription in T which was used as a control, are shown in Fig. 3A . To study the DNA sequence specificities of the complexes with different mobilities that were obtained, we carried out binding reactions in the presence of several different unlabeled competitor DNA segments. When the homologous DNA segment was added as competitor (50x molar excess), the bands of a set of complexes became drastically weakened, whereas for two other complexes with relatively small electrophoretic mobility shifts (one of which was found in higher amounts in the human cell lines than in the mouse cell lines), at most mirir competition occurred ( Fig. 3B and C Fig. 3B ] than for analysis of T cells [ Fig. 3C] ). In agreement with the results of the DNase I footprinting experiment, the highest amount of specific complex was obtained with extracts from the CTL cell line. All bands representing complexes disappeared upon boiling the extracts or treating them with high amounts of trypsin or papain, 0.5% sodium dodecyl sulfate, or 0.5% sarcosyl, while RNase A had no effect (data not shown). Based on these results and the fact that upon limited protease cleavages new complexes with decreased electrophoretic mobility shifts were formed (see below), the factors are believed to be proteins. We denote the proteins found to bind with high sequence specificities to the identified DNA sequence SL3-3 enhancer factor 1 (SEF1) proteins. Note that the distribution of bands due to different complexes with SEFi proteins did not appear to be identical for all cell lines (Fig. 3A to C) . The cytotoxic T-cell line CTL gave complexes both with lower and slightly higher mobilities compared with those obtained in substantial amounts with the different T-helper-cell lines. Note also the limited stability during electrophoresis of the complexes with the SEFi proteins, resulting in smearing between the positions of the complexes and the free DNA.
To determine whether the difference between T-cell and other cell lines in their contents of SEF1 proteins correlated with corresponding differences between cells of organs containing high amounts of T lymphocytes and cells from other organs, nuclear extracts were prepared from organs of CBA mice, and electrophoretic mobility shift experiments were performed. Primary thymocytes and splenocytes were found to be at least as rich in SEF1 proteins as T-cell lines, while kidney and liver cells contained very little of these proteins (Fig. 3D) . In a control experiment, the qualities of the nuclear extracts of the kidney and liver cells were confirmed by the fact that they contained a known transcription factor, NF1 (data not shown). The thymocytes were found to give a distribution of complexes corresponding to that of CTL, while the spleen-derived cells preferentially gave the fastermigrating complexes.
Methylation interference analysis of the complexes. To define contact residues on the DNA for the SEFi proteins, a methylation interference analysis was performed. DNA segments labeled at one 5' end were partially methylated by dimethyl sulfate and incubated with nuclear extract, the complexes with SEFi proteins as well as noncomplexed DNA segments were isolated from a native polyacrylamide gel, the DNA was cleaved with piperidine at the positions of methylation, and the DNA fragments were resolved on a sequencing type of polyacrylamide gel (see above). If any of the methyl groups introduced interfered with the binding of a specific protein, then the molecules of DNA methylated at that position would be selectively missing in the complex and, subsequently, in the corresponding sequencing gel ladder. When the two strands of a DNA segment containing the TGTGG sequence were analyzed in such an experiment, the isolated free DNA generated a characteristic ladder of strong guanine bands ( Fig. 4A and B, lanes 1 and 2) . The methylating agent reacted with guanines and, to a much lower extent, with adenines (35) . Nevertheless, in addition to guanine bands, many adenine bands were also identified in the ladder, although some of them were only identified on the original autoradiogram. The DNA in complexes within SEF1 was deficient in methylation at certain residues in the middle of the DNA segment ( Fig. 4A and B, lanes 3 to 5; summarized in Fig. 5) . Interestingly, the nucleotides found to be important for the formation of complexes with the SEF1 proteins were indistinguishable for the extracts of the three different lymphocyte cell lines. However, note that it cannot be excluded that methylation at an additional position(s) interfered with the formation of a certain SEF1 complex, because such an extra interference would not be detected in the mixture of other different complexes with the SEF1 proteins. The positions where methylation interferes with SEF1 binding include most, but not all, of the purines between positions 185 and 192, with methylation of the bordering adenine at position 192 causing only partial interference ( Fig. 4 and 5 ). Mutation analysis of the binding site. The binding of the SEF1 proteins to the DNA was analyzed further by testing the ability of the proteins to bind to DNA segments with the different mutations shown in Fig. 5 . While the wild-type DNA segment efficiently competed with the labeled DNA segment, the mutated DNA segments either did not compete at all (mutation 2) or competed with decreased efficiencies (Fig. 6A and B, mutations 1 and 3 to 6 ). The use of labeled DNA segments with the same mutations in the electrophoretic mobility shift assay led to a decrease in the complexes with SEF1 in a fashion corresponding to the results of the competition experiments (data not shown). Note that none of the mutant DNA segments selectively eliminated by competition subset of the complexes formed with the SEF1 proteins. Thus, the DNA-binding sites of the SEF1 proteins that create the different complexes also appear to be the same by this assay.
No competition with recognition sequences for other enhancer-binding transcription factors. Many enhancer-binding (Fig.  4) (47) Fig. 6C and D; for the ,u0 motif [competitor 3] , lack of competition was also confirmed with a 100-fold molar excess of the DNA segment). Only the homologous DNA segment was found to compete for binding, showing that the SEFi proteins are distinct from the factors that bind to these seven other recognition sequences.
Electrophoretic mobility shifts with nuclear extracts partialy digested with protease. To further characterize the different SEFi proteins, a limited treatment with protease was performed on different nuclear extracts, which were prepared with EDTA and PMSF as the only protease inhibitors (and not the six additional inhibitors otherwise added), prior to the electrophoretic mobility shift analysis (see above). Note that for many of the cell types, the extracts prepared in the presence of a decreased number of protease inhibitors gave complexes with decreased mobility shifts even before protease treatments (Fig. 7) , indicating that EDTA plus PMSF is not sufficient in all cell types to protect the SEFi proteins from protease attack during preparation.
Treatments of the extracts with proteinase K or protease V8 generated new nucleoprotein complexes with decreased electrophoretic mobility shifts. Proteinase K treatment yielded one major complex for each of the cell lines. A 50-fold molar excess of the homologous DNA segment could compete with the labeled DNA segment in the formation of this complex but a heterologous DNA segment could not, indicating that the sequence specificities of the SEFI proteins are retained after cleavage. Also, cleavage of the extracts with protease V8 yielded one complex for each cell type against which an excess of the homologous DNA segment could compete but a heterologous DNA segment could not (Fig. 7B) . Interestingly, while complexes with several different mobilities were obtained with uncleaved extracts, the decreased electrophoretic mobility shifts obtained with both proteases were to one position on the gel with the extracts from the different cell lines (cf. Fig. 7 with Fig. 3 and 6 ). The same effects of protease treatments were also seen with nuclear extracts of both murine and bovine spleen cells (Fig. 7) . Treatments of preformed complexes with proteinase K or protease V8 yielded corresponding results, as when protease treatments were before complex formation, although higher amounts of the proteases were needed (data not shown).
Site preferences of the protease cleavage of the SEFI proteins. Preferential protease cleavage of the SEFi proteins at a certain position(s) was further analyzed by treatments with different amounts of the proteases. A 100-fold variation in the quantities of proteinase K used only led to minor differences in the complexes that were obtained (Fig. 8) . While small amounts of a larger complex remained with the lowest quantity of proteinase K, increasing amounts of the protease only slightly decreased the abundance of the specific complex. Bands that could be competed against and that had the same migration as those obtained with proteinase K could also be obtained both with 0.1 and 1 ,ug of protease V8 (data not shown). Thus, there is a very high preference for cleavage with these two proteases at a certain position(s) in these proteins.
The protease quantities which created the preferred cleavage products did not have to correspond to the amounts needed to digest a protease inhibitor-free extract to the same extent because the protease inhibitor PMSF was used as a protection against protease attack during preparation of these nuclear extracts. However, for this study, the relative protease sensitivities, rather than the absolute values, within the SEFi proteins were of importance.
To address further the question of whether limited treatment of the different SEF1 proteins with different proteases created DNA-binding products with much less variable mobilities, we performed prolonged (3 h) electrophoresis of complexes obtained by treatment of extracts with proteinase K, protease V8, and two other proteases, papain and trypsin (Fig. 9) . The electrophoretic mobilities were not separated for the specific complexes formed with the different SEFi proteins after cleavage of the extracts of the different cell types with proteinase K, protease V8, or papain. Also, trypsin-digested nuclear extracts from the different cell types generated SEF1 protein complexes with equal mobilities, although with slightly larger electrophoretic mobility shifts compared with those obtained with the other three proteases.
The SEFi protein complexes obtained after the nuclear extracts were treated with proteases were not only found to 10 ,Lg create more distinct bands than with extracts not treated with protease but also to create complexes which were more stable during electrophoresis (cf. Fig. 3, 6 , and 9). Prolonged electrophoresis led untreated extracts to have a much higher degree of loss of band strength and smearing of bands between the positions of the complexes and the free DNA compared with those for protease-treated extracts (data not shown).
Analysis of possible protein-protein interactions. The most direct interpretation of the effects of the limited protease treatments on the electrophoretic mobilities of the complexes is that parts that did not bind to DNA were cleaved off from the SEFi proteins. However, an alternative possibility would be that one protein binds to the DNA sequence and then other, more protease-sensitive proteins can interact specifically with the DNA-binding protein and create complexes with different mobilities. However, the intermediary bands seen with extracts prepared with insufficient protease inhibition or after treatment with very low amounts of protease ( Fig. 7 ; data not shown) make this alternative less likely. In addition, no band indicative of complexes with only such a DNA-binding protein could be seen with extracts that were not treated with protease (Fig. 3, 6, 7, and 8) . Furthermore, no such band could be provoked when the binding reactions were performed in the presence of 1.5% of the detergents Nonidet P-40 or Triton X-100, which destabilize hydrophobic interactions (data not shown). To test further for the possible existence of proteins that were very protease sensitive, which would then have to be in molar excess and bind very efficiently to the DNA-binding protein, the proteinase K in treated nuclear extracts was inactivated by prolonged incubation with the protease inhibitor PMSF, and then more extract was added. This procedure did not result in a redistribution of material from the more rapidly migrating complex to the more slowly migrating complexes (data not shown), also arguing against the possibility that there were such very protease-sensitive proteins.
DISCUSSION
We detected interactions of the nuclear protein SEF1 with a specific DNA sequence that included but was not limited to the region 5'-CTGTGGTTAA-3' of the 72-bp DNA repeat in the enhancer of the T-lymphocyte-specific mouse retrovirus SL3-3. We found that such SEF1 proteins are much more abundant in cell lines of T lymphocytes and in lymphoid organs than in the other cell lines or organs tested, in agreement with the T-lymphocyte preference found in the activity of this segment of the enhancer. We also found that limited protease treatments cleave the SEFi proteins such that their DNA-binding domain(s) remains and creates complexes with indistinguishable electrophoretic mobilities and new properties.
Results of the DNase I footprinting assay that was initially used demonstrated that a dominant interaction with the 72-bp DNA repeat was located at the sequence that was studied, at least in the T-lymphocyte cell line CTL. Interactions with this DNA sequence were more difficult to demonstrate for other cell lines tested by the DNase I footprinting technique. This could be due to the lower concentration of interacting SEF1 proteins in the extracts of the other cell lines (Fig. 3A) . The concentrations of SEF1 proteins could be too low in those extracts to achieve the saturation of the DNA molecules with protein, which is necessary to avoid DNase I cleavage of free DNA obscuring footprints. Another possibility, which cannot be excluded at present, is that the SEF1 proteins from CTL, which create complexes both with lower and slightly higher mobilities than those found in substantial amounts in the other cell lines, have such DNA-binding properties that they create DNase I footprints more efficiently than do the other SEF1 proteins. Several protein-DNA interactions that were possible to analyze by electrophoretic mobility shift assay but not by DNase I footprinting, because of an equilibrium between free and bound DNA in solution that is too rapid (less than 1 min), have previously been reported in the immunoglobulin heavy-chain enhancer system (60) . During the course of this study, a protein from HeLa cells which binds to SV40 DNA in a gel retardation assay but not in a DNase I footprinting assay was also reported (55) .
When the remaining 38-bp repeat is deleted from a derivative of the SL3-3 enhancer carrying one copy each of the 34-and 38-bp repeats, the stimulation of transcription decreases about twofold in the T-lymphocyte cell lines CTL and EL-4, while no decrease in transcription has been seen in a cell line of the B-cell lineage, X-63-1, or in HeLa cells (Hallberg and Grundstrom, in preparation). Here we have reported that a mutation of the recognition sequence for the SEFi proteins decreases transcription in vivo twofold in the T-lymphocyte cell lines EL-4 and CTL, in contrast to the X-63-1 cell line, in which no decrease was observed ( Fig. 2 and Table 1 ). This strongly argues that the SEFl-binding site mediates the enhancer activity in T cells of the duplicated 38-bp sequence.
The observed twofold effect on transcription is significant for the assay method used (79) , but it is far from drastic. However, enhancer activity has been shown to result from the integrated function of multiple sequence elements (79; see also references therein) which bind trans-acting factors (9, 76 8, 1988 w cells less than fourfold, and all of them affected transcription less than sevenfold, although the effect of the complete enhancer was several thousand-fold (76, 79) . In light of these results, the level of the effect of mutating the SEFl-binding sequence of the SL3-3 enhancer studied here may turn out to be rather common for individual sequence elements of intact enhancers.
Homologies between several of the sequence elements have been pointed out in different enhancers (79) . The most commonly found sequence elements share the sequence 5'-TGTGG-3'. Such elements have even been called the core of the enhancers (31, 73) . The range of enhancers in which TGTGG sequences have been found includes also those with very high cell-type specificities (53, 71) . We have found that the TGTGG sequence of the SL3-3 enhancer is important for transcription in vivo in T-lymphocyte cell lines but not in other tested cells (Fig. 2 and Table 1 ) (Hallberg and Grundstrom, in preparation). How could such a common type of DNA sequence mediate different effects in different cell types? An explanation supported by the results of the present study is that the TGTGG sequence is only a common part of a family of longer DNA sequences that interact with proteins of different sequence specificities. Hence, we have found several different nucleotide positions outside of the TGTGG sequence of SL3-3 in which methylation of a purine or a nucleotide substitution inhibits the binding of the SEFi proteins (Fig. 4, 5 , and 6A and B). Similar sequences in many other enhancers differed from those of SL3-3 in several of these positions (79) . We also found that in the formation of complexes between the SEFi proteins and the SL3-3 sequence studied here, no competition was observed with any one of a set of binding sites for different DNAbinding proteins that affect transcription ( Fig. 6C and D) , including the two TGTGG-type sequences of the SV40 enhancer. These results indicate that the SEF1 proteins are distinct from several other proteins that bind to related sequences. During the course of this study, the two TGTGGtype sequences of the SV40 enhancer were shown to bind nuclear proteins that were distinct from each other (77) , despite the fact that these two nucleotide sequences were more related to each other than to the SEFl-binding sequence. Thus, the SEF1 proteins appear to belong to a TGTGG motif family of proteins that bind to related but distinct DNA sequences.
A trivial explanation for the qualitative or quantitative differences between complexes formed with extracts of different cell lines could be a difference in the protease contents, leading to various attacks in vitro on the DNAbinding proteins. To minimize such problems, we used a mixture of eight protease inhibitors in the preparations of the nuclear extracts (see above). If, instead, the extracts were prepared with only EDTA and PMSF as protease inhibitors, the complexes obtained with the CTL and myeloma cell lines demonstrated clear signs of protease attack on the SEFi proteins (decreased amounts of complex and complexes with decreased electrophoretic mobility shifts; Fig. 7 and data not shown). Also, with the first five of the eight added inhibitors listed earlier in this report, problems with protease attack on SEF1 remained for the CTL cell line (data not shown). Thus, addition of sufficient protease inhibitors is essential when cell type differences in the contents of transcription factors in nuclei are studied. With the eight inhibitors added, the CTL cell line yielded the same major complexes as the cell lines that showed the smallest protease problems, arguing that sufficient protease inhibition was obtained. The CTL cell line, in fact, yielded a complex with a higher electrophoretic mobility shift than those found in substantial amounts in other cell lines. This indicates that the set of complexes obtained with the different cell lines represent different SEFi proteins rather than proteins cleaved during preparation. However, the possibility of remaining artifact bands due to protease cleavage cannot be excluded. This is especially the case for the tissues, in which, in addition to the complexes obtained with the cell lines, complexes with lower electrophoretic mobility shifts were also obtained.
In the present study we have demonstrated that, on limited protease treatment, the SEFi proteins yield DNAbinding domains with less variable electrophoretic mobility shift effects on the DNA than the complexes with the nontreated proteins. Cleavage of the extracts with proteinase K, protease V8, or papain resulted in DNA sequencespecific complexes with nonseparated mobilities during electrophoresis for all the cell lines tested. Trypsin treatment of the extracts yielded complexes with slightly higher mobilities than those of the other complexes. This difference could indicate that the site(s) most efficiently cleaved with trypsin is at a position(s) that is slightly separated from the predominant cleavage sites of the other three proteases. Despite the stabilizing conditions of the electrophoretic mobility shift assay (12-14, 16, 66) , the complexes with the SEF1 proteins were not found to be completely stable; this was observed as smearing and a lower amount of complexed DNA, especially during prolonged electrophoresis. In contrast, the complexes with protease-cleaved SEF1 were much more stable (cf. the smearing after 1 h of electrophoresis of SEF1 in Fig.  3 and after 3 h of electrophoresis of protease-cleaved SEFi in Fig. 9 ). The higher stabilities and the much less variable mobilities during electrophoresis of the protease-cleaved SEF1 proteins are, together with the differential protease sensitivities of the different parts of the proteins, intruiging in the context of current ideas concerning the structure of enhancer and promoter-binding proteins. A favored hypothesis for the ability of enhancer and promoter structures to tolerate changes of distances between protein-binding sites on the DNA and to show functional bidirectionality without apparent symmetry of these binding sites is a structure of enhancer-binding proteins composed of two functional domains linked by a flexible stem: a DNA-binding domain and a domain that interacts with the transcription machinery (67) . A structure with separate domains linked by a flexible stem is known to exist in several procaryotic DNA-binding proteins: the lambda repressor cI (26, 50, 74) , the lambda Cro protein (10, 68 and references therein), the catabolite activator protein CAP (44) , and the LexA protein (39) . Support for the existence of such a type of structure among DNA-binding proteins also comes from results of studies of an upstream-activating sequence in yeasts (30) and receptors of steroid hormones (17, 78) . During the course of this study, a CCAAT box-binding protein was also shown to have a structurally distinct DNA-binding domain (27) . The demonstrated effects of proteinase K, protease V8, papain, and trypsin experimentally support the hypothesis that the enhancer-binding SEF1 proteins also have such a structure. The flexible stem would then correspond to the protein structure found to be most vulnerable to protease; and the domain(s) of protein-protein interactions with other components of the transcription machinery, with its ability to move relative to the rest of the complex, would then destabilize it in the gel.
The primary criteria for dividing important control elements for the initiation of transcription of eucaryotic proteincoding genes into enhancer and promoter elements have been the ability of enhancer elements to function also when they are located far from the point of initiation of transcription and to support different types of steric restrictions. The results presented here argue that the SEF1 proteins have a flexible hinge region between their DNA-binding domain(s) and a domain(s) that mediates interactions that are important for other properties of these proteins. It is tempting to speculate that the degree of the flexibility of such a hinge region in enhancer-binding proteins could be a parameter of major importance for creating the steric flexibility used to distinguish enhancer elements from promoter elements.
The differences observed in the electrophoretic mobilities of the SEFi proteins were found mainly before a domain(s) (36) , and has an enhancer element that is not preferentially active in T cells (7) despite the fact that it only has a few sequence differences compared with the enhancer element of SL3-3 (36) . Interestingly, the enhancer of AKV is different from that of SL3-3 in the SEFl-binding site; there is a C instead of a T at position 190 (Fig. 5) . We have shown here that a DNA segment with the SL3-3 sequence binds SEF1 much better than a segment with the AKV sequence, which is represented by mutation 4 in Fig.  6A and B. Thus, the differences in T-cell preference, both in the viruses and in their enhancers, correlates with differences in the efficiencies of the DNA sequences of SL3-3 and AKV studied here to bind to a transcription factor, SEF1, that is preferentially made in T cells. It is therefore tempting to speculate that the binding of SEFi is an essential factor for the T-cell tropism of SL3-3 and the ability of this virus to cause leukemia. This hypothesis should be tested in additional experiments, both in vitro and in different in vivo systems.
